HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philippe Moerman Selected Research

Adenosarcoma

3/2017Potential Targets' Analysis Reveals Dual PI3K/mTOR Pathway Inhibition as a Promising Therapeutic Strategy for Uterine Leiomyosarcomas-an ENITEC Group Initiative.
11/2005CD10, estrogen and progesterone receptor expression in ovarian adenosarcoma.
3/2003Immunohistochemical determination of hormone receptors in uterine adenosarcomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philippe Moerman Research Topics

Disease

27Neoplasms (Cancer)
05/2018 - 11/2005
10Endometrial Neoplasms (Endometrial Cancer)
10/2016 - 08/2005
6Carcinoma (Carcinomatosis)
01/2018 - 12/2008
5Sarcoma (Soft Tissue Sarcoma)
03/2017 - 12/2004
5Carcinosarcoma
01/2017 - 12/2004
4Breast Neoplasms (Breast Cancer)
08/2014 - 01/2008
4Ovarian Neoplasms (Ovarian Cancer)
09/2013 - 11/2008
3Endometrial Stromal Sarcoma
03/2017 - 12/2004
3Adenosarcoma
03/2017 - 03/2003
3Endometrioid Carcinoma
10/2016 - 12/2008
2Hydatidiform Mole (Molar Pregnancy)
01/2018 - 08/2016
2Leiomyosarcoma
03/2017 - 12/2004
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2017 - 12/2015
2Adenocarcinoma
10/2016 - 01/2008
2Microsatellite Instability
10/2016 - 10/2015
2Abscess
08/2015 - 11/2006
2Uterine Neoplasms (Uterine Cancer)
12/2013 - 12/2008
2Neoplasm Metastasis (Metastasis)
10/2013 - 11/2008
2Carcinogenesis
12/2008 - 03/2003
2Adenosarcoma of the uterus
12/2004 - 06/2004
1Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
01/2018
1Smooth Muscle Tumor
03/2017
1Margins of Excision
01/2017
1Papillary Cystadenoma
10/2016
1Choriocarcinoma
08/2016
1Tics (Tic)
08/2016
1Persistent Fetal Circulation Syndrome
05/2016
1Aneuploidy (Aneuploid)
09/2015
1Wounds and Injuries (Trauma)
08/2015
1Ovarian Epithelial Carcinoma
12/2014
1Brain Neoplasms (Brain Tumor)
03/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2011
1Kidney Diseases (Kidney Disease)
01/2011
1Triple Negative Breast Neoplasms
11/2008
1Pneumoperitoneum
11/2008
1Prader-Willi Syndrome (Syndrome, Prader-Willi)
10/2008

Drug/Important Bio-Agent (IBA)

6Progesterone Receptors (Progesterone Receptor)IBA
10/2016 - 06/2004
6Biological ProductsIBA
12/2009 - 03/2003
4human ERBB2 proteinIBA
10/2016 - 04/2008
4PlatinumIBA
12/2014 - 04/2009
4Estrogen ReceptorsIBA
02/2011 - 01/2008
3Biomarkers (Surrogate Marker)IBA
03/2017 - 11/2005
3Paclitaxel (Taxol)FDA LinkGeneric
01/2017 - 03/2014
3Estrogens (Estrogen)FDA Link
10/2016 - 06/2004
3ParaffinIBA
03/2014 - 12/2008
3Hormones (Hormone)IBA
12/2006 - 03/2003
2RNA (Ribonucleic Acid)IBA
01/2017 - 03/2014
2Carboplatin (JM8)FDA LinkGeneric
01/2017 - 03/2014
2DNA (Deoxyribonucleic Acid)IBA
09/2015 - 12/2004
2Messenger RNA (mRNA)IBA
12/2013 - 09/2013
2Proteins (Proteins, Gene)FDA Link
02/2011 - 04/2009
1Keratin-20 (Cytokeratin 20)IBA
05/2018
1Keratin-7 (Cytokeratin 7)IBA
05/2018
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
01/2018
1Ribosomal Proteins (Ribosomal Protein)IBA
03/2017
1IfosfamideFDA LinkGeneric
01/2017
1Phenobarbital (Luminal)FDA Link
10/2016
1Trastuzumab (Herceptin)FDA Link
10/2016
1IGF-I-IGFBP-3 complexFDA Link
10/2016
1Etoposide (VP 16)FDA LinkGeneric
08/2016
1Methotrexate (Mexate)FDA LinkGeneric
08/2016
1Long Noncoding RNAIBA
05/2016
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2015
1VimentinIBA
10/2015
1Keratins (Keratin)IBA
10/2015
1dactolisibIBA
10/2015
1AZD 6244IBA
10/2015
1Circulating Tumor DNAIBA
09/2015
1dichlorobis(azomycin)platinum IIIBA
09/2015
1Carbon DioxideIBA
08/2015
1P-2 (P 2)IBA
12/2014
1Glucose (Dextrose)FDA LinkGeneric
05/2014
1Formaldehyde (Formol)FDA Link
03/2014
1VaccinesIBA
12/2013
1Taxoids (Taxanes)IBA
08/2011
1TubulinIBA
08/2011
1StathminIBA
02/2011
1TOR Serine-Threonine KinasesIBA
02/2011
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
02/2011
1Imatinib Mesylate (Gleevec)FDA Link
02/2011
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2011
1Fatty Acids (Saturated Fatty Acids)IBA
01/2011
1Transcription Factors (Transcription Factor)IBA
12/2008
1Oxygen (Dioxygen)IBA
11/2008

Therapy/Procedure

9Therapeutics
01/2017 - 11/2006
4Adjuvant Chemotherapy
02/2013 - 09/2007
3Neoadjuvant Therapy
01/2017 - 10/2013
2Drug Therapy (Chemotherapy)
01/2018 - 10/2015
2Lymph Node Excision (Lymph Node Dissection)
12/2015 - 08/2014
2Immunotherapy
12/2013 - 09/2013
2Lasers (Laser)
01/2011 - 04/2009
1Salpingo-oophorectomy
01/2018
1Chemoradiotherapy
01/2017
1Curettage
08/2016
1Hysterectomy
12/2015
1Molecular Targeted Therapy
03/2014
1Laparotomy
11/2008
1Orchiectomy (Orchidectomy)
10/2008
1Orchiopexy
10/2008
1Conservative Treatment
01/2008